DYNA THERAPEUTICS LIMITED

Active London

Research and experimental development on biotechnology

Research and experimental development on biotechnology
D

DYNA THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 13 Feb 2026 Active London, United Kingdom website.com
Research and experimental development on biotechnology
Accounts
Confirmation
Net assets N/A
Total assets N/A
Total Liabilities N/A
Charges None No charges registered

Contact & Details

Contact

Registered Address

125 Wood Street London EC2V 7AW United Kingdom

Full company profile for DYNA THERAPEUTICS LIMITED (17031873), an active company based in London, United Kingdom. Incorporated 13 Feb 2026. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

3 active
Status
De Jongh, Lisanne DaruniiDirectorDutchNetherlands3730 Mar 2026Active
Phan, VienSecretaryUnknownUnknown13 Feb 2026Active
Tzima, EleniDirectorGreek,americanUnited Kingdom5013 Feb 2026Active

Shareholders

Shareholders (2)

Eleni Tzima
50.0%
1,386,700
John Selwyn Reader
50.0%
1,386,700

Persons with Significant Control

Persons with Significant Control (3)

3 Active 2 Ceased

Eleni Tzima

Greek,american

Active
Notified 13 Feb 2026
Residence United Kingdom
DOB October 1975
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

John Selwyn Reader

British

Active
Notified 13 Feb 2026
Residence United Kingdom
DOB September 1970
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Oxford Science Enterprises Plc

Unknown

Active
Notified 30 Mar 2026
Nature of Control
  • Ownership Of Shares 50 To 75 Percent
  • Voting Rights 50 To 75 Percent

Eleni Tzima

Ceased 30 Mar 2026

Ceased

John Selwyn Reader

Ceased 30 Mar 2026

Ceased

Group Structure

Group Structure

DYNA THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
7 Apr 2026CapitalAllotment of shares (GBP 37.45038) on 30 Mar 2026
7 Apr 2026CapitalAllotment of shares (GBP 72.45038) on 30 Mar 2026
2 Apr 2026OfficersAppointment of Ms Lisanne Darunii De Jongh as director on 30 Mar 2026
2 Apr 2026Persons With Significant ControlCessation of John Selwyn Reader as a person with significant control on 30 Mar 2026
2 Apr 2026Persons With Significant ControlCessation of Eleni Tzima as a person with significant control on 30 Mar 2026
7 Apr 2026 Capital

Allotment of shares (GBP 37.45038) on 30 Mar 2026

7 Apr 2026 Capital

Allotment of shares (GBP 72.45038) on 30 Mar 2026

2 Apr 2026 Officers

Appointment of Ms Lisanne Darunii De Jongh as director on 30 Mar 2026

2 Apr 2026 Persons With Significant Control

Cessation of John Selwyn Reader as a person with significant control on 30 Mar 2026

2 Apr 2026 Persons With Significant Control

Cessation of Eleni Tzima as a person with significant control on 30 Mar 2026

Recent Activity

Latest Activity

Allotment of shares (GBP 37.45038) on 30 Mar 2026

3 weeks ago on 7 Apr 2026

Allotment of shares (GBP 72.45038) on 30 Mar 2026

3 weeks ago on 7 Apr 2026

Appointment of Ms Lisanne Darunii De Jongh as director on 30 Mar 2026

4 weeks ago on 2 Apr 2026

Cessation of John Selwyn Reader as a person with significant control on 30 Mar 2026

4 weeks ago on 2 Apr 2026

Cessation of Eleni Tzima as a person with significant control on 30 Mar 2026

4 weeks ago on 2 Apr 2026